China SXT Pharmaceuticals (SXTC) Common Equity (2018 - 2026)
China SXT Pharmaceuticals (SXTC) reported Common Equity of $29.71 million for fiscal Q4 2026 (quarter ended Mar 31, 2026), up 92.4% from $15.44 million a year earlier.
Powered by 
Analysis
China SXT Pharmaceuticals (SXTC) Common Equity (2018 - 2026) Analysis & Trends
Dating back to fiscal Q4 2018, China SXT Pharmaceuticals' Common Equity record includes 17 quarters.
- Common Equity has a five-year compound annual growth rate of 13.2% (FY2021 to FY2026).
- By fiscal year, Common Equity came in at $15.44 million in FY2025 (+10.8%), $13.93 million in FY2024 (-5.2%), $14.69 million in FY2023 (-8.7%) and $16.08 million in FY2022 (+0.8%).
- The fiscal Q4 2026 figure ranks as the highest quarterly Common Equity in data going back to fiscal Q4 2018.
- The high point for year-over-year Common Equity in five years was fiscal Q2 2025 (growth of 196.2%); the low point was fiscal Q2 2024 (a decline of 65.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | China SXT Pharmaceuticals | 33,069.96 | -85.92 Mn | - | 29.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 29.71 Mn |
| Sep 30, 2025 | 20.23 Mn |
| Mar 31, 2025 | 15.44 Mn |
| Sep 30, 2024 | 15.03 Mn |
| Mar 31, 2024 | 13.93 Mn |
| Sep 30, 2023 | 5.08 Mn |
| Mar 31, 2023 | 14.69 Mn |
| Sep 30, 2022 | 14.55 Mn |
| Mar 31, 2022 | 16.08 Mn |
| Sep 30, 2021 | 13.79 Mn |
| Mar 31, 2021 | 15.96 Mn |
| Sep 30, 2020 | 18.52 Mn |
| Mar 31, 2020 | 9.40 Mn |
| Sep 30, 2019 | 11.41 Mn |
| Mar 31, 2019 | 11.11 Mn |
| Sep 30, 2018 | 4.60 Mn |
| Mar 31, 2018 | 3.29 Mn |
API Access
China SXT Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();